US FDA approves Glenmark's metformin tablets
MUMBAI (Reuters) - The U.S. Food and Drug Administration has approved Glenmark Pharmaceuticals Ltd's diabetes drug metformin hydrochloride tablets in multiple strengths, the regulator's Web site said on Friday.
The agency also approved Aurobindo Pharma Ltd's benazepril hydrochloride tablets to be sold in multiple strengths in the United States. It is used to treat high blood pressure.
(Reporting by Bharghavi Nagaraju; Editing by Prem Udayabhanu)
© Thomson Reuters 2009 All rights reserved
One Year Later
Mumbai held tearful memorials and police staged a show of strength as it marked the first anniversary of militant raids that killed 166 people and pushed up tensions with Pakistan. Slideshow | Full Coverage
Liberhan Commission Report
The government published a long awaited report, recently leaked, accusing BJP leaders of a role in the 1992 destruction of the Babri mosque in Ayodhya. Full Article
